Overview

Capsaicin for Cerebral Perfusion Augmentation

Status:
Not yet recruiting

Trial end date:
2023-02-01

Target enrollment:

Participant gender:

Summary

To determine the effect of capsaicin upon serial transcranial Doppler (TCD) markers of cerebral blood flow (CBF). Methods Serial TCD testing in 30 participants with cerebrovascular risk factors. Capsaicin doses .66 and .99 μMol. Outcomes: peak systolic and end-diastolic velocities in the middle cerebral artery (MCA), mean velocity (MV), pulsatility index (PI), CBF index, arterial pressure, and perceived pungency (PP) in five minutes intervals up to 20 minutes.

Phase:

Phase 2

Details

Lead Sponsor:

Instituto Mexicano del Seguro Social

Collaborator:

Centenario Hospital Miguel Hidalgo

Treatments:

Capsaicin